
Organometallics p. 4075 - 4081 (1999)
Update date:2022-07-29
Topics:
Reynolds, Michael A.
Guzei, Ilia A.
Logsdon, Bradley C.
Thomas, Leonard M.
Jacobson, Robert A.
Angelici, Robert J.
Ultraviolet photolysis of hexanes solutions containing the complexes M(CO)6 (M = Cr, Mo, W) or CpMn(CO)3 (Cp = η5-C5H5) and excess thiophene (T*) (T* = 2,5-dimethylthiophene (2,5-Me2T), benzothiophene (BT), or dibenzothiophene (DBT)) produces the η1(S)-T* complexes (CO)5M(η1(S)-T*) 1-8 or Cp(CO)2Mn(η1(S)-T*) 9-11, respectively. However, when T* = DBT and M = Mo, a mixture of two products results, which includes (CO)5Mo(η1(S)-DBT), 4a, and the π-complex (CO)3Mo(η6-DBT), 4b, as detected by 1H NMR spectroscopy. Only the complexes (CO)5W(η1(S)-DBT) (1), (CO)5Cr(η1(S)-DBT) (5), and Cp(CO)2Mn(η1(S)-DBT) (9) were sufficiently stable (several days) to be isolated and characterized by elemental analyses. Rates of DBT ligand displacement by CO (1 atm) at room temperature decreased in the order 5 > 1 > 9. Single-crystal, X-ray structural determinations are reported for 1, 5, and 9. The tilt angle (θ) of the DBT ligand in these and related complexes is discussed in terms of π-back-bonding to the DBT ligand.
View Morewebsite:http://www.acrospharmatech.com
Contact:+1-3234804688
Address:Flat/RM 1502,Easey Commercial building 253-261 Hennessy Road,Wanchai,HongKong
Wuhan Sunrise Pharmaceutical Technology Co., Ltd
Contact:+86-27-83314682
Address:Room 340, New material Industrial base No.17, Gu Tian Five Lu , Qiaokou District, Wuhan , China
NIGNXIA XINDACHANG TECHNOLOGY CO.,LTD
Contact:86-0951-7815345
Address:North side of Qiyuan Road, west side of Yuanfeng Highway, New Material Park, Ningdong Energy and Chemical Industry Base, Ningxia,China
UK SHAREPOINT INTERNATIONAL TRADE CO., LTD(expird)
Contact:44-20-31299469
Address:FLAT 107 25 INDESCON SQUARE LONDON UNITED KINGDOM E14 9DG
NINGBO PANGS CHEM INT’L CO.,LTD.
Contact:+86-574-27666845
Address:FLOOR 21,BUILDING NO.11,XIN TIAN DI,NO.689 SHI JI ROAD,NINGBO CHINA
Doi:10.1002/zaac.201600271
(2016)Doi:10.1002/adsc.202000198
(2020)Doi:10.1007/s11172-020-2925-1
(2020)Doi:10.1039/j39710002265
(1971)Doi:10.3797/scipharm.aut-01-205
(2001)Doi:10.1248/cpb1953.5.78
(1957)